Ms. Lorea Coronado-Garcia, UNDP Greening Health Systems Specialist, delivered a presentation on 8 June on the challenges of the SPHS Member Agencies' global procurement and use of pharmaceuticals, as well as on opportunities for improvement.
2. SPHS Task Team is, through a transparent and
inclusive engagement process, leveraging its
normative and market power, lowering the
environmental impact of its procurement, with a final
aim of improving human health and well-being.Global perspectives on
health and environment
3. Hyderabad, India 2013
Pauline Göthberg. “Swedish healthcare causing environmental problems in other
countries”. April 2016. PowerPoint PresentationGlobal production
global consumption
global footprint
4. Linking our work to the
Sustainable
Development Goals and
Key Focus Areas
5. Strategy on Engaging with Suppliers
and Manufacturers on Green Health
Procurement
Engagement with
suppliers and
manufacturers
6. • List of key hazardous products for substitution in UNDP procurement
• In the list: TB (antibiotic) and HIV/AIDS (antiretroviral)
pharmaceuticals
Source: http://www.savinglivesustainably.org/knowledge-practice/contribution/undp-with-health-care-
without-harm-sustainable-procurement-practices-in-the-global-health-aid-market-project-funded-by-
skoll-foundation-and-un-foundation/Ff777B.html
Green procurement
criteria
recommendations
Chemical Substitutions
7. A UNDP Guide For
Procurement
Practitioners
• Measure and monitor the status and
progress of healthcare procurement
related to the compliance with
International Environmental Conventions
• Indicators - a building block of the GPIH
and the compliance with International
Environmental Conventions
8. Environmental
Assessments of
Suppliers and
Manufacturers of Health
Commodities and
Services
A user-friendly and
dynamic tool which
provides comprehensive
overview of the
environmental
performance of suppliers
and manufacturers of
health commodities and
services
Questionnaire
and OET
Interested in testing this tool, which was developed
in consultation with leading technical experts?
Please contact us at info@savinglivesustainably.org
i
10. Country Assessments
To assess the possible
environmental impact of GF grants,
rapid assessments on healthcare
waste were carried out
Generally applicable recommendations
to all GF-funded health programmes
Context specific recommendations to
particular country
http://www.eurasia.undp.org/content/rbec/en/home/library/hiv_aids/rapid-assessment-healthcare-waste-global-fund.html
12. Healthcare Waste
Management Toolkit
UNDP developed a practical
toolkit for healthcare waste
management.
http://www.eurasia.undp.org/content/rbec/en/home/library/hiv_aids/rapid-assessment-healthcare-waste-global-fund.html
Part C will be launched
shortly
13. Sustainable Public Health
Procurement Trainings
UNDP-UNEP-HCWH support
government officials to design
and implement sustainable
public health procurement
policies that equally factor in
the social, economic and
environmental impact of their
operations.
Interested in hosting a training in
your organization?
Please contact us at
info@savinglivesustainably.org
iEngagement with the
key stakeholders
15. THANK YOU FOR YOUR
ATTENTION
www.savinglivesustainably.org
Join the conversation and follow us:
#act4health
Editor's Notes
My work at UNDP, and in support of the SPHS, looks at how to integrate sustainable procurement in the health sector into UNDP programmes and practices, and which lessons and tools can be shared across the UN. While I am not able to speak on the behalf of hospitals, I glad to share more about how our work, at UNDP, is overlapping with the pharmaceutical (and broader health sector) procurement. Please let me know if this would be interesting for you.
Explain what UNDP does related to health: resilient lives
UNDP health and environment work - one pillar of the health team work
UNDP purchasing need of pharmaceuticals
Key SPHS assets highlighted were the leverage of its normative, operational and financial strengths to introduce sustainable procurement practices in the global health aid market, across the UN system and the SPHS global network.
Global production, global consumption
Pharmaceuticals in the environment have been detected in all UN regions: Occur globally – include image of study? – Mentioned in previous Safe Pharma webinar
Pharmaceuticals-in-the-environment.org
India is fast emerging as an outsourcing destination for global pharmaceutical majors, which are looking at reducing manufacturing and drug development costs.
Solution has to address both production and consumption
Solution has to address both production and consumption – SDG 12
You can see the concentration of dots near the SDGS – this is a representative graphic of the success stories featured on our platform
SDG 3 – Good health and wellbeing
SDG 12 – Responsible consumption and production
SDG 17 – Partnership for the goals
Much of our work focuses on health
Of our focus areas, largely relevant to today’s webinar are medical products, waste management, and water.
Supplier engagement
In November, SPHS published its Engagement Strategy to work in collaboration with suppliers and manufacturers to introduce procurement in the global health sector.
The publication helped identify and prioritize different products and product categories, develop a plan for engaging our supply chain and laid out milestones for the strategy
improved storage, responsible disposal
Recommendations for use of green procurement criteria
Guidance and targets to substitute hazardous products purchased by the UN for its health programs
List of key products based on procurement volume and environmental impact: Antiretrovirals, Rapid Diagnostic Test Kits, Medical devices (syringes, thermometers, gloves, blood pressure measuring device and catheters), TB drugs, male condoms, hormonal implants and healthcare waste technologies
Environmental footprint assessment based on toxicity, carbon footprint, and Resource Depletion
Phase in with multi-stakeholder engagement process: UN suppliers, UN procurement departments and multilateral funding institutions
Objectives
Developing and implementing a guidance note on an initial priority list of a green procurement criteria
Developing a list of products that remove priority toxic chemicals from production, products and waste
Engaging with suppliers and manufacturers of pharmaceuticals and medical devices to stimulate the development of greener products and manufacturing processes, subsequently reducing the environmental burden of the health sector
Outcomes
Initial priority list of green procurement criteria and the monitoring of their implementation
Recommendations on specifications and how to evaluate and select healthcare products based on the established green procurement criteria
Assessment of the environmental footprint from UNDP purchased health care products based on three environmental pillars: Carbon Footprint, Toxicity and Resource Depletion
Effective phase-in of the green procurement criteria through a multi-stakeholder engagement process
We also designed tools to support our procurement officers in their efforts to integrate sustainability criteria into their daily roles.
We developed a tool and published a guide that supports procurement officers to check for compliance with 5 international environmental conventions on chemicals.
5 Conventions covered in the Guide are:
Basel Convention on the Control of Transboundary Movements of Hazardous Wastes and Their Disposal
Rotterdam Convention on the Prior Informed Consent Procedure for Certain Hazardous Chemicals and Pesticides in International Trade
Vienna Convention for the Protection of the Ozone Layer and the Montreal Protocol on Substances That Deplete the Ozone Layer
Stockholm Convention on Persistent Organic Pollutants (POPs)
Minamata Convention on Mercury
The tool runs on excel and produces this automated dashboard indicating levels of compliance.
Also speak regarding SPHS Gavi Cold Chain
Purpose: To assess the possible environmental impact of GF grants, rapid assessments on healthcare waste were carried out
UNDP has been a strategic partner of the GF for the last 10 years.
To assess the possible environmental impact caused by waste created through its GF project implications, country assessments on healthcare waste were carried out were conducted in Bosnia and Herzegovina, Kyrgyzstan, Tajikistan, Uzbekistan and Zimbabwe.
The implementation of the GF health project will create non-hazardous waste but also dozens of toxic, infectious or otherwise hazardous waste types, such as expired pharmaceuticals, contaminated packing materials, needles and syringes containing pathogens and others.
Depending on the country specific context, different options may exist for the disposal and treatment of pharmaceutical waste generated by the project.
Analysis of waste management
How is the hazardous waste (for each waste group, e.g. infectious waste, pharmaceutical waste, chemical waste, radioactive waste, cytotoxic waste) handled during the steps: segregation, collection, transportation, storage and disposal?
ARVs and ACTs include different pharmaceuticals and a separate hazard assessment should be carried out for each pharmaceutical product.
Pharmaceutical waste defined as:
Pharmaceuticals that are expired or no longer needed; items contaminated by or containing pharmaceuticals;
Domestic (municipal)n waste: Non-hazardous pharmaceutical waste
Chemical waste: Hazardous pharmaceutical waste
Definition: Pharmaceutical waste includes expired, unused, unwanted, spilled and contaminated pharmaceutical products, medicines and vaccines. It also includes all sera and bottles, boxes and vials used to contain pharmaceuticals, which are no longer required.
WHO recommends burying of pharmaceutical waste in areas away from water source and in soils of low permeability
Persistent and toxic
Also as part of the work, a Healthcare Waste Management Toolkit Package for Global Fund Practitioners and Policy Makers (with various components) was developed
The toolkit is intended to help to reduce risks from the generation and disposal of HCW, especially the disposal of unwanted or unused pharmaceuticals, potentially infectious waste and other hazardous waste
Excerpts from Part A:
Burying of waste not only takes up valuable land space, it also causes air, water and soil pollution, chemicals and pesticides into the earth and groundwater.
Chemical risks from HCW are often underestimated. Waste from health programmes often creates chemical risk as the materials are reactive; they are unstable, and may produce toxic fumes, gases and vapours when mixed with water or under other conditions such as heat or pressure.
The general public can be at risk through the direct exposure to hazardous substances or indirectly through the polluted environment: water, soil, and air
To be able to share these projects and lessons with our procurement teams, we developed the Sustainable public health procurement training, in collaboration with UN Environment.
As we see it, the supply chain is the new frontier for sustainable operations and programming.
Online Knowledge-Hub on Good Practices in Sustainable Health Procurement and Manufacturing
Constantly being updated